Ibritumomab Tiuxetan and Moxetumomab Pasudotox-tdfk
Determining the interaction of Ibritumomab Tiuxetan and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Moxetumomab pasudotox-tdfk Intravenous
- Ibritumomab Tiuxetan-Moxifloxacin
- Ibritumomab Tiuxetan-Moxifloxacin (Systemic)
- Ibritumomab Tiuxetan-Moxifloxacin Hydrochloride
- Ibritumomab Tiuxetan-Moxifloxacin Injection
- Ibritumomab Tiuxetan-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Ibrutinib
- Moxetumomab Pasudotox-tdfk-Ibrutinib Capsules
- Moxetumomab Pasudotox-tdfk-Ibrutinib Tablets
- Moxetumomab Pasudotox-tdfk-Ibu
- Moxetumomab Pasudotox-tdfk-IBU Tablets
- Moxetumomab Pasudotox-tdfk-Ibu-2